Tag: psoriasis market research

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Psoriasis Market Size During 2025–2029?

The psoriasis market size has seen significant growth in recent years. It is anticipated to expand from $26.45 billion in 2024 to $28.93 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.4%. This historical growth can be attributed to factors such as epidemiology, enhanced patient awareness and education, and improved healthcare infrastructure and access.

The psoriasis market is anticipated to exhibit significant expansion in the coming years. It is projected to achieve a size of $40.93 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.1%. The expected growth over this period can be ascribed to factors such as regulatory clearances, evolving patient preferences, an aging demographic, heightened public awareness, and the introduction of new therapeutic options. Prominent trends within the forecast timeframe include continuous advancements in research and development, the increasing prevalence of biologics and targeted therapies, the development of oral small molecule treatments, the adoption of personalized medicine, the growth of telemedicine and digital health, an emphasis on patient-centric care, the availability of biosimilars, and the incorporation of artificial intelligence and machine learning.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Which Drivers Are Shaping The Psoriasis Industry’s Market Share?

The increasing prevalence of individuals with psoriasis is a primary factor driving the Psoriasis market. This condition stems from issues related to the immune system, genetics, and environmental elements. The rise in psoriasis patients observed over the past few years can be chiefly attributed to shifts in climate, heightened stress, and unhealthy lifestyles. As per the World Psoriasis Day consortium, 125 million people globally – 2 to 3% of the total population have psoriasis. Consequently, this growing prevalence of psoriasis patients is anticipated to propel the growth of the psoriasis over forecast period.

What Are The Emerging Segments Gaining Attention In The Psoriasis Market?

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Tropical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

What Trends Are Expected To Drive The Psoriasis Market?

In the psoriasis market, combination therapy stands as an evolving trend. This treatment strategy involves the simultaneous application of two distinct psoriasis treatments. When two drugs possessing different mechanisms of action are combined, this approach, known as combination therapy, achieves a greater effect than that derived from monotherapy, which relies on a single drug. Studies indicate that combination therapy alleviates psoriasis symptoms more effectively than a single treatment and is associated with fewer side effects. An example of combination therapy for managing active psoriatic arthritis (PsA) is the combination of taltz (ixekizumab) with methotrexate, developed by Eli Lilly and Company.

Who Are The Primary Competitors In The Global Psoriasis Market?

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Psoriasis Market?

North America was the largest region in the psoriasis market in 2024. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Psoriasis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

Browse Through More Reports Similar to the Global Psoriasis Market 2025, By The Business Research Company

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Pharmaceutical Drugs And Biologics Logistics Market 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-and-biologics-logistics-market

Analgesics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Psoriasis Market?

Over the past years, the psoriasis market size has seen robust growth. The market is set to expand from a value of $26.45 billion in 2024 to reaching $28.93 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this substantial growth in the historical period include epidemiology, increased patient awareness and education, as well as enhancements in healthcare infrastructure and access.

The psoriasis market is predicted to experience substantial expansion in the upcoming years. The market is set to rise to “$40.93 billion by 2029 at a compound annual growth rate (CAGR) of 9.1%. The progression during the future period is ascribed to factors such as regulatory permissions, preferences of patients, the ageing populace, elevated consciousness, and the rollout of innovative treatments. The primary trends during the forecast period consist of advancements in R&D, biologic and targeted therapies, oral small molecule treatments, tailored medicine, digital healthcare and telemedicine, care focussed on the patient, biosimilars, and the application of artificial intelligence and machine learning.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Which Growth Drivers Are Shaping The Psoriasis Market Outlook?

The escalating number of cases of individuals suffering from psoriasis is escalating the Psoriasis market. Psoriasis is a result of a variety of factors, including the immune system, genetic inheritance, and environmental conditions. The recent spike in psoriasis sufferers can be primarily traced back to the alteration in climate, intense stress, and unhealthy living patterns. As stated by the World Psoriasis Day consortium, the disease affects 125 million people around the globe – constituting 2 to 3% of the whole population. As such, the swelling number of psoriasis patients is predicted to spur the expansion of the psoriasis market in the forecast period.

Which Segmentation Factors Are Critical In The Psoriasis Market Analysis?

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Tropical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

What Are The Dominant Trends Currently Seen In The Psoriasis Market?

The rising trend in the psoriasis market is the use of combination therapy. This approach to treatment involves using two distinct psoriasis therapies simultaneously. Combination therapy, specifically when two medicinal products with different methods of operation are integrated, provides a more enhanced effect than monotherapy, which uses a single drug. It has been evidenced in research that this therapy method suppresses psoriasis symptoms more successfully than single therapy techniques and has fewer side effects. A notable example of combination therapy applied for actively managing Psoriatic Arthritis (PsA) is the pairing of taltz (ixekizumab) and methotrexate, a therapeutic model proposed by Eli Lilly and Company.

Who Are The Dominant Players In The Psoriasis Market Today?

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Psoriasis Market?

North America was the largest region in the psoriasis market in 2024. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Is the Outlook for the Artificial Intelligence (AI) In Predictive Toxicology Market Heading Into 2029?#_x000D_

In the past few years, there has been a notable increase in the size of the psoriasis market. The market is set to expand from $26.45 billion in 2024 to $28.93 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. The surge in growth during the historical phase can be ascribed to factors such as epidemiology, increased patient consciousness and education, and the development and accessibility of the healthcare infrastructure._x000D_

_x000D_

Anticipations are running high for a robust expansion of the psoriasis market in the upcoming years. The market value is set to burgeon to “$40.93 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.1%. The projected growth during this period is driven by factors such as regulatory clearances, consumer inclinations, an aging society, heightened consciousness, and the debut of innovative therapies. The period is likely to witness significant trends such as progress in R&D, adoption of biologics and targeted therapies, deployment of oral small molecule treatments, the rise of personalized medicine, the advent of telemedicine and digital health, patient-directed care, emergence of biosimilars, and the integration of artificial intelligence and machine learning._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp_x000D_

_x000D_

#Which Factors Are Pushing The Artificial Intelligence (AI) In Predictive Toxicology Market Forward?#_x000D_

Anticipated growth in the artificial intelligence (AI) in predictive toxicology market is largely due to the rising necessity for efficient and ethical drug discovery methods. Drug discovery is a multifaceted and evolving procedure involving the detailed study, production, and assessment of chemical compounds in order to unearth viable therapeutic agents for disease relief and general health improvement. This advanced and responsible approach to drug discovery is motivated by the growing prevalence of chronic illnesses, the emerging trend toward personalized medicine and an increase in age-related diseases. AI in predictive toxicology enhances drug discovery by proficiently examining extensive datasets to anticipate potential toxicological results, thus expediting the drug development process while upholding ethical practices. As an illustration, in June 2023, the pharmaceutical R&D expenditure in Europe was reported to be $49,500 million (€44,500 million), a roughly 6.45% increase from $46,500 million (€42,533 million) in 2021, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical industry trade association. This growing necessity for efficient and ethical drug discovery procedures, therefore, is fueling the rise of AI in predictive toxicology market._x000D_

_x000D_

_x000D_

The psoriasis market covered in this report is segmented – _x000D_

_x000D_

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor _x000D_

2) By Drug Types: Small molecules, Biologics  _x000D_

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis _x000D_

4) By Route Of Administration: Oral, Tropical, Injectable _x000D_

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce_x000D_

_x000D_

Subsegments:_x000D_

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab) _x000D_

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone) _x000D_

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast) _x000D_

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade) _x000D_

_x000D_

#What Are The Leading Trends And Opportunities In The Artificial Intelligence (AI) In Predictive Toxicology Sector?#_x000D_

In the psoriasis market, the utilization of combination therapy is a rising trend. This form of treatment introduces two separate psoriasis treatments simultaneously. The use of two drugs with distinctive mechanisms in combination therapy results in an effect that surpasses that of monotherapy (usage of a solitary drug). Research infers that the effectiveness of combination therapy in alleviating psoriasis symptoms exceeds that of single therapy, and it also has fewer side effects. Taltz (ixekizumab) and methotrexate, developed by Eli Lilly and Company, is a prime example of combination therapy implemented for the treatment of active psoriatic arthritis (PsA)._x000D_

_x000D_

#Which Organizations Are Driving Progress In The Artificial Intelligence (AI) In Predictive Toxicology Industry?#_x000D_

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy_x000D_

_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report_x000D_

_x000D_

#Which Region Is Expected To Experience The Highest Growth In The Artificial Intelligence (AI) In Predictive Toxicology Industry?#_x000D_

North America was the largest region in the psoriasis market in 2024. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Psoriasis Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

Over the past few years, the size of the psoriasis market has experienced significant growth. The market is set to expand from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Factors such as epidemiology, increased awareness and education among patients, and access to healthcare infrastructure have contributed to the growth during the historic period._x000D_

_x000D_

In the upcoming years, substantial growth is projected in the psoriasis market size. The market is expected to escalate to $40.93 billion by 2029, with a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the forecast period include regulatory approvals, patient preferences, an aging populace, heightened awareness, and the introduction of new therapies. Key trends predicted for this period encompass advancements in research and development, focus on biologics and targeted therapies, development of oral small molecule therapies, increased focus on personalized medicine, adoption of telemedicine and digital health, emphasis on patient-centric care, the rise of biosimilars, and the utilization of artificial intelligence and machine learning._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp_x000D_

_x000D_

#Which Factors and External Forces Are Driving Demand in the Psoriasis Market?#_x000D_

The Psoriasis market is experiencing growth due to increased cases of psoriasis. The condition is primarily triggered by factors such as the immune system, genetics, and environmental issues. The recent surge in psoriasis cases can be primarily linked to stress, drastic changes in the climate, and unhealthy lifestyle habits. As per data from the World Psoriasis Day consortium, psoriasis affects 2 to 3% of the world’s population, which is around 125 million people globally. As a result, the increasing number of psoriasis individuals is anticipated to fuel the expansion of the psoriasis market throughout the predicted period._x000D_

_x000D_

#Which Segments in the Psoriasis Offer the Most Growth?#_x000D_

The psoriasis market covered in this report is segmented – _x000D_

_x000D_

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor _x000D_

2) By Drug Types: Small molecules, Biologics  _x000D_

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis _x000D_

4) By Route Of Administration: Oral, Tropical, Injectable _x000D_

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce_x000D_

_x000D_

Subsegments:_x000D_

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab) _x000D_

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone) _x000D_

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast) _x000D_

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade) _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Psoriasis Market?# Market?#_x000D_

North America was the largest region in the psoriasis market in 2024. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Which Cutting-Edge Market Trends Are Expected to Drive thePsoriasis Market’s Growth?#_x000D_

One of the rising trends in the psoriasis market is the use of combination therapy. It means simultaneous administration of two different treatments for psoriasis. The efficacy of combination therapy, which amalgamates two drugs with varying action mechanisms, is shown to surpass that of monotherapy, which involves the application of a single drug. Multiple studies indicate that combination therapy relieves psoriasis symptoms more effectively than a standalone treatment and results in fewer side effects. The combination therapy for the treatment of active psoriatic arthritis (PsA), such as taltz (ixekizumab) with methotrexate, created by Eli Lilly and Company, is one such example._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Psoriasis Market?#_x000D_

Psoriasis refers to a skin condition that typically affects the knees, elbows, trunk, and scalp and results with a rash with itchy, scaly spots. The primary contributing factor may be an immune system issue wherein infection-fighting cells unintentionally kill healthy skin cells._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Psoriasis Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the psoriasis industry has seen substantial growth in the past few years. It is predicted to increase from $26.56 billion in 2024 to $29.5 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. Factors such as epidemiology, increased patient awareness and education, and advancements in healthcare infrastructure and accessibility have contributed to the growth seen in the historical period.

What Is the Forecast for the Psoriasis Market Size Through 2029?

The market for psoriasis is set for substantial expansion in the coming years, projected to reach $42.34 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. This growth during the predicted period is due to several factors including regulatory authorizations, patient choices, an aging demographic, heightened awareness, and the rollout of new treatments. Key trends anticipated during this period encompass advancements in research and development, biologics and targeted therapies, oral small molecule therapies, custom-tailored medicine, digital healthcare and telemedicine, patient-focused care, biosimilars, as well as the incorporation of artificial intelligence and machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

What are the Key Market Players in Psoriasis Market and How They’re Evolving?

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

What Are the Primary Growth Drivers in the Psoriasis Market?

An increase in the number of individuals suffering from psoriasis is pushing the growth of the Psoriasis market. Psoriasis results from a combination of factors including the immune system, genetics, and environmental conditions. The primary contributors to the recent surge in psoriasis cases are changes in climate, stress, and poor lifestyle choices. Data from the World Psoriasis Day consortium suggests that psoriasis affects 125 million people worldwide, accounting for 2 to 3% of the global population. Consequently, the escalating prevalence of psoriasis is anticipated to stimulate the expansion of the psoriasis market throughout the forecast period.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

What Are the Leading Segments in the Global Psoriasis Industry?

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Tropical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

What Are the Key Market Trends in the Psoriasis Industry?

The practice of combination therapy is a rising trend within the psoriasis market. This refers to the simultaneous use of two separate psoriasis treatments. Outcomes are generally better when two medications with varied mechanisms of action are teamed up in combination therapy, as opposed to relying on monotherapy, or the utilization of a solitary drug. Research indicates that combination therapy alleviates the symptoms of psoriasis more effectively and has less side effects than a single therapy. A prime example of combination therapy specifically for active psoriatic arthritis (PsA) is the pairing of taltz (ixekizumab) with methotrexate, a development courtesy of Eli Lilly and Company.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

What Is the Regional Outlook for the Psoriasis Market?

North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

This Report Delivers Insight On:

1. How big is the psoriasis market, and how is it changing globally?

2. Who are the major companies in the psoriasis market, and how are they performing?

3. What are the key opportunities and risks in the psoriasis market right now?

4. Which products or customer segments are growing the most in the psoriasis market?

5. What factors are helping or slowing down the growth of the psoriasis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the psoriasis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Psoriasis Market Size From 2025 to 2034?

The size of the psoriasis market has expanded swiftly in the past years. The market is projected to escalate from a value of $26.56 billion in 2024 to around $29.5 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. This growth over the historic period is largely due to factors such as epidemiology, enhanced patient awareness and education, along with improved healthcare infrastructure and accessibility.

The market size for psoriasis is anticipated to experience substantial growth in the coming years. It is predicted that by 2029, the market will increase to $42.34 billion, reflecting a compound annual growth rate (CAGR) of 9.4%. This growth during the projected period is linked to regulatory approvals, patient choices, an aging population, enhanced consciousness, and the emergence of new therapies. The forecast period will also see significant trends like advancements in R&D, the use of biologics and targeted therapies, oral small molecule therapies, personalized medical treatment, digital health and telemedicine, patient-focused care, biosimilars, and the disruption by artificial intelligence and machine learning.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Which Primay Drivers Are Accelerating Growth in the Psoriasis Market?

The Psoriasis market is being propelled by an increase in the number of patients suffering from psoriasis. The condition of psoriasis emerges largely due to the immune system, genetics, and environmental factors. The surge in the number of people affected by psoriasis in recent years can primarily be linked to environmental changes, stress, and unhealthy living conditions. The World Psoriasis Day consortium reveals that psoriasis affects 125 million individuals worldwide, accounting for 2 to 3% of the total population. Consequently, the escalating prevalence of psoriasis is anticipated to stimulate the expansion of the psoriasis market over the projected period.

Which Primary Segments of the Psoriasis Market Are Driving Growth and Industry Transformations?

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Tropical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

Which Regions Are Key Players in the Growth of the Psoriasis Market?

North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Psoriasis Market?

The psoriasis market is witnessing a rising trend in the form of combination therapy, an innovative treatment approach that merges two diverse psoriasis treatments concurrently. The impact of merging two drugs with unique mechanisms of action, known as combination therapy, surpasses the outcome derived from monotherapy, which incorporates only a single drug. Research indicates that combination therapy alleviates psoriasis symptoms more efficiently than solitary therapy and has fewer side effects. Eli Lilly and Company devised a perfect example of combination therapy through Taltz (ixekizumab) and methotrexate for the management of active psoriatic arthritis (PsA).

View the full report here:

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

What Parameters Are Used to Define the Psoriasis Market?

Psoriasis refers to a skin condition that typically affects the knees, elbows, trunk, and scalp and results with a rash with itchy, scaly spots. The primary contributing factor may be an immune system issue wherein infection-fighting cells unintentionally kill healthy skin cells.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of thePsoriasis Market?

The rising prevalence of psoriasis is contributing to the growth of the psoriasis market. Psoriasis is a condition caused by a combination of genetic, immune, and environmental factors. With increasing instances linked to stress, unhealthy lifestyles, and climate change, around 125 million people globally, or 2-3% of the population, suffer from psoriasis. Therefore, the growing number of patients is expected to boost the psoriasis market in the forecast period.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

What is the Predicted Annual Growth Rate of thePsoriasis Market Impact Industry Trends by 2034?

The psoriasis market size has grown rapidly in recent years. It is expected to grow from $26.56 billion in 2024 to $29.5 billion in 2025, at a compound annual growth rate (CAGR) of 11.1%. Growth in this market is attributed to rising epidemiological awareness, patient education and awareness, improvements in healthcare infrastructure, and better access to treatment options.

The psoriasis market is anticipated to grow robustly over the next few years, reaching $42.34 billion by 2029 at a CAGR of 9.4%. This growth will be fueled by regulatory green lights, evolving patient demands, an aging population, greater awareness, and the emergence of innovative treatments. Key trends include enhanced R&D, biologics and precision-targeted therapies, oral small molecule drugs, personalized care, digital health tools like telemedicine, patient-first strategies, biosimilars, and the use of AI and machine learning.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

Which Cutting-Edge Market Trends Are Expected to Drive thePsoriasis Market’s Growth?

Combination therapy is becoming more common in the psoriasis treatment market. This involves using two different treatments together, as studies show it can alleviate symptoms more effectively than using a single treatment. For example, the combination of taltz (ixekizumab) with methotrexate developed by Eli Lilly and Company is used to treat active psoriatic arthritis (PsA).

Who Are the Major Industry Players Accelerating Growth in thePsoriasis Market?

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

Which Primary Segments of the Psoriasis Market Are Driving Growth and Industry Transformations?

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Tropical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of thePsoriasis Market?# Market?

North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Psoriasis Market 2025, By The Business Research Company:

Colorectal Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Antifungals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Dermatology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the psoriasis market?

The value of the psoriasis market has surged dramatically in the past few years. It is projected to increase from $26.56 billion in 2024 to $29.5 billion in 2025, illustrating a compound annual growth rate (CAGR) of 11.1%. Factors such as increased disease statistics, better patient education and awareness, and enhanced healthcare access and infrastructure have contributed to the remarkable growth in the past periods.

What will be the psoriasis market size in the future?

The size of the psoriasis market is anticipated to witness robust expansion in the succeeding years. By 2029, it is presumed to inflate to $42.34 billion at a 9.4% compound annual growth rate (CAGR). Various factors contributing to this growth in the estimated period include regulatory approvals, preferences of patients, an aging demography, heightened awareness, and the introduction of innovative treatments. Major trends during this period include advancements in research and development, the use of biologics and targeted therapies, oral small molecule therapies, personalized medical treatments, telemedicine, digital healthcare, patient-focused care, biosimilars, as well as the employment of artificial intelligence and machine learning.

Get your psoriasis market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

What main drivers are fueling expansion in the psoriasis market?

An increase in the number of psoriasis cases is fuelling the Psoriasis market. Various factors such as the immune system, genetics, and environment play a significant role in causing psoriasis. The surge in psoriasis cases in recent years can be primarily linked to climate change, stress, and unhealthy lifestyle choices. The World Psoriasis Day consortium states that globally, psoriasis affects 125 million people, which equates to about 2 to 3% of the total population. Therefore, the escalating prevalence of psoriasis patients is projected to bolster the psoriasis market growth over the forecast period.

What key areas define the segmentation of the global psoriasis market?

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Tropical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Who are the dominant players expanding their reach in the psoriasis market?

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

How are evolving market trends shaping psoriasis Strategies?

In the psoriasis market, combination therapy is a rising trend. This innovative treatment merges two separate psoriasis treatments concurrently. It’s suggested that the outcome is more powerful when two medications with differing methods of action are combined, a process known as combination therapy, as compared to monotherapy which entails use of a single drug. Research points to combination therapy being more effective in alleviating psoriasis symptoms and causing fewer side effects than single therapy. For instance, a combination therapy for treating active psoriatic arthritis (PsA) is a blend of taltz (ixekizumab) with methotrexate, a product of Eli Lilly and Company.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

Which regions are emerging as leaders in the psoriasis market?

North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Colorectal Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Antifungals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Dermatology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the psoriasis market?

The value of the psoriasis market has surged dramatically in the past few years. It is projected to increase from $26.56 billion in 2024 to $29.5 billion in 2025, illustrating a compound annual growth rate (CAGR) of 11.1%. Factors such as increased disease statistics, better patient education and awareness, and enhanced healthcare access and infrastructure have contributed to the remarkable growth in the past periods.

What will be the psoriasis market size in the future?

The size of the psoriasis market is anticipated to witness robust expansion in the succeeding years. By 2029, it is presumed to inflate to $42.34 billion at a 9.4% compound annual growth rate (CAGR). Various factors contributing to this growth in the estimated period include regulatory approvals, preferences of patients, an aging demography, heightened awareness, and the introduction of innovative treatments. Major trends during this period include advancements in research and development, the use of biologics and targeted therapies, oral small molecule therapies, personalized medical treatments, telemedicine, digital healthcare, patient-focused care, biosimilars, as well as the employment of artificial intelligence and machine learning.

Get your psoriasis market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

What main drivers are fueling expansion in the psoriasis market?

An increase in the number of psoriasis cases is fuelling the Psoriasis market. Various factors such as the immune system, genetics, and environment play a significant role in causing psoriasis. The surge in psoriasis cases in recent years can be primarily linked to climate change, stress, and unhealthy lifestyle choices. The World Psoriasis Day consortium states that globally, psoriasis affects 125 million people, which equates to about 2 to 3% of the total population. Therefore, the escalating prevalence of psoriasis patients is projected to bolster the psoriasis market growth over the forecast period.

What key areas define the segmentation of the global psoriasis market?

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Tropical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Who are the dominant players expanding their reach in the psoriasis market?

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

How are evolving market trends shaping psoriasis Strategies?

In the psoriasis market, combination therapy is a rising trend. This innovative treatment merges two separate psoriasis treatments concurrently. It’s suggested that the outcome is more powerful when two medications with differing methods of action are combined, a process known as combination therapy, as compared to monotherapy which entails use of a single drug. Research points to combination therapy being more effective in alleviating psoriasis symptoms and causing fewer side effects than single therapy. For instance, a combination therapy for treating active psoriatic arthritis (PsA) is a blend of taltz (ixekizumab) with methotrexate, a product of Eli Lilly and Company.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

Which regions are emerging as leaders in the psoriasis market?

North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Colorectal Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Antifungals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Dermatology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: